Abstract
BACKGROUND: The new coronavirus infection (SARS-CoV-2), better known as COVID-19, quickly evolved into a worldwide pandemic with a significant public health burden. Currently, there are no approved drugs or preventive therapeutic strategies to combat infection. However, there are hundreds of clinical studies around the world to discover effective treatments for COVID-19.
 AIM: The purpose of the research is to conduct a content analysis of the published clinical trials devoted to the treatment of COVID-19, as well as to the synthesis of clinical experience in order to gain insight into potentially effective drugs.
 MATERIALS AND METHODS: Clinical results published in PubMed, Medline, eLIBRARY, Cochrane Library.
 RESULTS: The review summarized the results of clinical studies of potential therapeutic drugs used in COVID-19 therapy.
 CONCLUSIONS: By the 15 of August 2021 no medications had been registered to treat the infection.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
